2m 2m 2m 2m 2m 2m 2m
SERA PROGNSTCS-A (SERA)
NASDAQ
$1.97-$0.01 (-0.51%)
Price as of Nov 13, 2026 2:02 PM EST- $76.8MMarket Cap
- -32.88%1-Year Change
- Medical DevicesIndustry
SERA PROGNSTCS-A (SERA)
$1.97-$0.01 (-0.51%)
SERA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.98 | ||
Change | +$0.04 (+2.06%) | ||
Open | $1.97 | ||
High | $2.06 | ||
Low | $1.92 | ||
Previous Close | $1.94 | ||
Volume | 18,801 | ||
30-Day Average Volume | 36,918 | ||
1-Week Change | -4.81% | ||
1-Month Change | -4.35% | ||
1-Year Change | -32.88% | ||
3-Year Change | 17.16% | ||
5-Year Change | -81.72% | ||
Fundamentals | |||
Shares Outstanding | 38.8M | ||
Total Assets | $80.0M | ||
Market Cap | $76.8M | ||
Enterprise Value | $72.8M | ||
Period: QTR TTM FY | |||
Revenue | $42,000.00 | ||
Net Income | -$8.1M | ||
Free Cash Flow | -$7.4M | ||
EBIT | -$8.1M | ||
EBITDA | -$7.9M | ||
Net Working Capital | $21.7M | ||
EPS | -$0.16 | ||
Enterprise Value/EBITDA | -9 | ||
Enterprise Value/Revenue | 1,734 | ||
P/B | 1 | ||
P/E | -12 | ||
PEG | -1 | ||
Price/Free Cash Flow | -10 | ||
Price/Operating Cash Flow | -11 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue